Treatment Targets for Right Ventricular Dysfunction in Pulmonary Arterial Hypertension

Right ventricle (RV) dysfunction is the strongest predictor of mortality in pulmonary arterial hypertension (PAH), but, at present, there are no therapies directly targeting the failing RV. Although there are shared molecular mechanisms in both RV and left ventricle (LV) dysfunction, there are impor...

Descripción completa

Detalles Bibliográficos
Autores principales: Prisco, Sasha Z., Thenappan, Thenappan, Prins, Kurt W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
State-of-the-Art Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7775863/
https://www.ncbi.nlm.nih.gov/pubmed/33426379
http://dx.doi.org/10.1016/j.jacbts.2020.07.011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7775863/
https://www.ncbi.nlm.nih.gov/pubmed/33426379
http://dx.doi.org/10.1016/j.jacbts.2020.07.011

Ejemplares similares